{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:28:10Z","timestamp":1791563290552,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T00:00:00Z","timestamp":1737504000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007338","name":"Foundation for Barnes-Jewish Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016477","name":"CareDx","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016477","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ekir.2025.01.026","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T04:11:41Z","timestamp":1738210301000},"page":"1152-1162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Thrombotic Microangiopathy After Kidney Transplantation: Insights Into Genetic Etiology and Clinical Outcomes"],"prefix":"10.1016","volume":"10","author":[{"given":"Massini","family":"Merzkani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyein","family":"Chann Wai Lynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Rajashekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Progar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowena Delos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuja","family":"Java","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2025.01.026_bib1","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2025.01.026_bib2","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2025.01.026_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ekir.2020.10.009","article-title":"Complement in secondary thrombotic microangiopathy","volume":"6","author":"Palma","year":"2020","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2025.01.026_bib4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.0000000000000182","article-title":"Epidemiology, outcomes, and complement gene variants in secondary thrombotic microangiopathies","volume":"18","author":"Werion","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.01.026_bib35","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.kint.2024.05.021","article-title":"An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group","volume":"106","author":"Nester","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.01.026_bib5","article-title":"Thrombotic microangiopathy after kidney transplantation: An underdiagnosed and potentially reversible entity","volume":"8","author":"\u00c1vila","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2025.01.026_bib6","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.ajkd.2003.07.008","article-title":"Thrombotic microangiopathy after renal transplantation in the United States","volume":"42","author":"Reynolds","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2025.01.026_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.trre.2017.10.001","article-title":"De novo thrombotic microangiopathy after kidney transplantation","volume":"32","author":"Garg","year":"2018","journal-title":"Transplant Rev (Orlando)"},{"key":"10.1016\/j.ekir.2025.01.026_bib8","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1600-6143.2010.03156.x","article-title":"Thrombotic microangiopathy after kidney transplantation","volume":"10","author":"Noris","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2025.01.026_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2215\/CJN.02790707","article-title":"Novel methods for tracking long-term maintenance immunosuppression regimens","volume":"3","author":"Buchanan","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.01.026_bib10","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2215\/CJN.00670109","article-title":"Sensitivity of billing claims for cardiovascular disease events among kidney transplant recipients","volume":"4","author":"Lentine","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.01.026_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.ekir.2025.01.026_bib12","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ekir.2019.04.003","article-title":"A\u00a0multimodality approach to assessing Factor I genetic variants in atypical hemolytic uremic syndrome","volume":"4","author":"Java","year":"2019","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.ekir.2025.01.026_bib13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ckj\/sfv101","article-title":"Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome","volume":"8","author":"Thomas","year":"2015","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.ekir.2025.01.026_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.ajkd.2018.11.012","article-title":"An ex\u00a0vivo test of complement activation on endothelium for individualized eculizumab therapy in hemolytic uremic syndrome","volume":"74","author":"Galbusera","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2025.01.026_bib15","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2025.01.026_bib16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/tvst.9.9.37","article-title":"Functional analysis of rare genetic variants in complement factor I (CFI) using a serum-based assay in advanced age-related macular degeneration","volume":"9","author":"Java","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/j.ekir.2025.01.026_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2023.152410","article-title":"Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic","volume":"228","author":"Hallam","year":"2023","journal-title":"Immunobiology"},{"key":"10.1016\/j.ekir.2025.01.026_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.molimm.2018.06.230","article-title":"The C3-R735W variant results in a hyperactive C3 that associates with atypical haemolytic uremic syndrome and C3-glomerulopathy","volume":"102","author":"Tortajada","year":"2018","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ekir.2025.01.026_bib19","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/eji.201243196","article-title":"Analysis of genes coding for CD46, CD55, and C4b-binding protein in patients with idiopathic, recurrent, spontaneous pregnancy loss","volume":"43","author":"Mohlin","year":"2013","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.ekir.2025.01.026_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1254759","article-title":"Genetic investigation of Nordic patients with\u00a0complement-mediated kidney diseases","volume":"14","author":"Rydberg","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2025.01.026_bib21","article-title":"Clinicopathologic implications of complement genetic variants in kidney transplantation","volume":"8","author":"Ren","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2025.01.026_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.909503","article-title":"Post-transplant thrombotic microangiopathy due to a pathogenic mutation in complement factor I in a patient with membranous nephropathy: Case report and review of literature","volume":"13","author":"Saleem","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.ekir.2025.01.026_bib23","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12882-023-03326-8","article-title":"Thrombotic microangiopathies after kidney transplantation in modern era: Nosology based on chronology","volume":"24","author":"Von Tokarski","year":"2023","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2025.01.026_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227445","article-title":"Clinical and pathological features of thrombotic microangiopathy influencing long-term kidney transplant outcomes","volume":"15","author":"Teixeira","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2025.01.026_bib25","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ajt.2024.01.029","article-title":"De novo thrombotic microangiopathy after kidney transplantation in adults: Interplay between complement genetics and multiple endothelial injury","volume":"24","author":"Dessaix","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2025.01.026_bib26","article-title":"Thrombotic microangiopathy in the renal allograft: Results of the TMA Banff working group consensus on pathologic diagnostic criteria","volume":"36","author":"Afrouzian","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2025.01.026_bib27","article-title":"The loss of glycocalyx integrity impairs complement factor H binding and contributes to cyclosporine-induced endothelial cell injury","volume":"10","author":"Teoh","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ekir.2025.01.026_bib28","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1681\/ASN.2012111064","article-title":"Cyclosporine induces endothelial cell release of complement-activating microparticles","volume":"24","author":"Renner","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2025.01.026_bib29","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.transproceed.2012.07.039","article-title":"De novo thrombotic microangiopathy after kidney transplantation: Clinical features, treatment, and long-term patient and graft survival","volume":"44","author":"Caires","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2025.01.026_bib30","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.kint.2024.02.014","article-title":"Assessment of epidemiology and outcomes of adult patients with kidney-limited thrombotic microangiopathies","volume":"105","author":"Maisons","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.01.026_bib31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/ajkd.2003.50058","article-title":"De novo thrombotic microangiopathy in renal transplant recipients: A comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathy","volume":"41","author":"Schwimmer","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2025.01.026_bib32","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.kint.2017.02.025","article-title":"Severe hypertension with renal thrombotic microangiopathy: What happened to the usual suspect?","volume":"91","author":"Van Laecke","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2025.01.026_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2025.01.026_bib34","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ekir.2024.01.013","article-title":"\u201cEculizumab First\u201d in the management of posttransplant thrombotic microangiopathy","volume":"9","author":"Maritati","year":"2024","journal-title":"Kidney Int Rep"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024925000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T18:49:33Z","timestamp":1762627773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024925000518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2468024925000518"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2025.01.026","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombotic Microangiopathy After Kidney Transplantation: Insights Into Genetic Etiology and Clinical Outcomes","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2025.01.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}